Ocugen Statistics

Total Valuation

Ocugen has a market cap or net worth of $309.55 million. The enterprise value is $297.74 million.

Market Cap	309.55M
Enterprise Value	297.74M

Important Dates

The last earnings date was Friday, May 9, 2025, before market open.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

Ocugen has 292.03 million shares outstanding. The number of shares has increased by 10.88% in one year.

Current Share Class	292.03M
Shares Outstanding	292.03M
Shares Change (YoY)	+10.88%
Shares Change (QoQ)	+0.37%
Owned by Insiders (%)	1.60%
Owned by Institutions (%)	26.54%
Float	287.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	58.94
Forward PS	n/a
PB Ratio	17.49
P/TBV Ratio	19.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	65.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.60, with a Debt / Equity ratio of 2.00.

Current Ratio	2.60
Quick Ratio	2.24
Debt / Equity	2.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-62.41

Financial Efficiency

Return on equity (ROE) is -248.97% and return on invested capital (ROIC) is -84.05%.

Return on Equity (ROE)	-248.97%
Return on Assets (ROA)	-61.33%
Return on Invested Capital (ROIC)	-84.05%
Return on Capital Employed (ROCE)	-119.90%
Revenue Per Employee	$47,600
Profits Per Employee	-$605,316
Employee Count	95
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.44% in the last 52 weeks. The beta is 4.24, so Ocugen's price volatility has been higher than the market average.

Beta (5Y)	4.24
52-Week Price Change	-41.44%
50-Day Moving Average	0.75
200-Day Moving Average	0.85
Relative Strength Index (RSI)	74.60
Average Volume (20 Days)	5,474,294

Short Selling Information

The latest short interest is 69.60 million, so 23.83% of the outstanding shares have been sold short.

Short Interest	69.60M
Short Previous Month	68.23M
Short % of Shares Out	23.83%
Short % of Float	24.22%
Short Ratio (days to cover)	22.38

Income Statement

In the last 12 months, Ocugen had revenue of $4.52 million and -$57.51 million in losses. Loss per share was -$0.21.

Revenue	4.52M
Gross Profit	-27.95M
Operating Income	-57.04M
Pretax Income	-50.86M
Net Income	-57.51M
EBITDA	-54.34M
EBIT	-57.04M
Loss Per Share	-$0.21

Full Income Statement

Balance Sheet

The company has $37.80 million in cash and $31.82 million in debt, giving a net cash position of $5.98 million or $0.02 per share.

Cash & Cash Equivalents	37.80M
Total Debt	31.82M
Net Cash	5.98M
Net Cash Per Share	$0.02
Equity (Book Value)	15.91M
Book Value Per Share	0.05
Working Capital	27.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$50.90 million and capital expenditures -$1.05 million, giving a free cash flow of -$51.95 million.

Operating Cash Flow	-50.90M
Capital Expenditures	-1.05M
Free Cash Flow	-51.95M
FCF Per Share	-$0.18

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,261.43%
Pretax Margin	-1,271.12%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Ocugen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.88%
Shareholder Yield	-10.88%
Earnings Yield	-18.93%
FCF Yield	-17.11%

Analyst Forecast

The average price target for Ocugen is $6.00, which is 466.04% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	466.04%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	185.99%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ocugen has an Altman Z-Score of -6.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.21
Piotroski F-Score	2